IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI
Open Access
- 4 May 2017
- journal article
- research article
- Published by Springer Nature in Neuroradiology
- Vol. 59 (6) , 555-562
Abstract
Purpose Currently, isocitrate dehydrogenase (IDH) mutation and 1p/19q co-deletion are proven diagnostic biomarkers for both grade II and III oligodendrogliomas (ODs). Non-invasive diffusion-weighted imaging (DWI), susceptibility-weighted imaging (SWI), and dynamic susceptibility contrast perfusion-weighted imaging (DSC-PWI) are widely used to provide physiological information (cellularity, hemorrhage, calcifications, and angiogenesis) of neoplastic histology and tumor grade. However, it is unclear whether DWI, SWI, and DSC-PWI are able to stratify grades of IDH-mutant and 1p/19q co-deleted ODs. Methods We retrospectively reviewed the conventional MRI (cMRI), DWI, SWI, and DSC-PWI obtained on 33 patients with IDH-mutated and 1p/19q co-deleted ODs. Features of cMRI, normalized ADC (nADC), intratumoral susceptibility signals (ITSSs), normalized maxim CBV (nCBV), and normalized maximum CBF (nCBF) were compared between low-grade ODs (LGOs) and high-grade ODs (HGOs). Receiver operating characteristic curve and logistic regression were applied to determine diagnostic performances. Results HGOs tended to present with prominent edema and enhancement. nADC, ITSSs, nCBV, and nCBF were significantly different between groups (all P < 0.05). The combination of SWI and DSC-PWI for grading resulted in sensitivity and specificity of 100.00 and 93.33%, respectively. Conclusions IDH-mutant and 1p/19q co-deleted ODs can be stratified by grades using cMRI and advanced magnetic resonance imaging techniques including DWI, SWI, and DSC-PWI. Combined ITSSs with nCBV appear to be a promising option for grading molecularly defined ODs in clinical practice.Keywords
Funding Information
- Leading Project of the Department of Science and Technology of Fujian Province (2016Y0101)
- Special Funds of Provincial Finance of Fujian Province (BPB-CDR2013)
- Research Foundation for Young Scholars of the Health Department of Fujian Province (2013-1-34)
This publication has 50 references indexed in Scilit:
- IDH1 Mutations Are Early Events in the Development of Astrocytomas and OligodendrogliomasThe American Journal of Pathology, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profileMolecular Cancer, 2008
- Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell lineMolecular Cancer, 2008
- Diffuse glioma growth: a guerilla warActa Neuropathologica, 2007
- Prediction of oligodendroglial tumor subtype and grade using perfusion weighted magnetic resonance imagingJournal of Neurosurgery, 2007
- High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusionJournal of Magnetic Resonance Imaging, 2007
- Cerebral Blood Volume Measurements and Proton MR Spectroscopy in Grading of Oligodendroglial TumorsAmerican Journal of Roentgenology, 2007
- Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumoursNeuroradiology, 2006
- Oligodendroglioma. The princess margaret hospital experience (1958–1984)Cancer, 1993